Sign in
Taking people in United StatesNo phase

Studies how genes and surroundings may play a part in blood and lymph cancers

Studies families to learn how genes and exposures may contribute to blood and lymph cancers.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
Family Study of Lymphoproliferative Disorders
Status
Recruiting
People taking part
3,000 people, planned
Started
1 Apr 2004
Expected to end
31 Dec 2029
Type of study
Observational
Record updated
2 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for families with at least 2 living blood relatives who have a lymphoproliferative disorder, such as lymphoma, chronic lymphocytic leukemia or multiple myeloma.

Age
18 Years to 100 Years
Sex
All sexes can join.
Disease stage
Lymphoproliferative disorder (blood and lymph node cancers); no stage is given.

The registry criteria, word for word

Show the criterionShow less

Other criteria

  • At least 2 living, blood related relatives, affected with a lymphoproliferative disorder

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • Mayo ClinicRochester, United StatesContact: Clinical Trials Referral OfficeTaking people

About the trial

What the trial wants to find out

Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Genetic Epidemiology of Lymphoproliferative Disorders
Plain-language title
Studies how genes and surroundings may play a part in blood and lymph cancersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT00626496, who can take part
Record updated
2 November 2026